Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor
- 21 September 2021
- journal article
- research article
- Published by Springer Nature in Nature Catalysis
- Vol. 4 (9) , 775-782
Abstract
No abstract availableKeywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Enzyme Toolbox: Novel Enantiocomplementary Imine ReductasesChemBioChem, 2014
- Redesigning and characterizing the substrate specificity and activity of Vibrio fluvialis aminotransferase for the synthesis of imagabalinProtein Engineering, Design and Selection, 2012
- Engineering the third wave of biocatalysisNature, 2012
- Development of an Amine Dehydrogenase for Synthesis of Chiral AminesAngewandte Chemie International Edition, 2012
- Status of protein engineering for biocatalysts: how to design an industrially useful biocatalystCurrent Opinion in Chemical Biology, 2011
- Generation of random mutant libraries with multiple primers in a single reactionJournal of Virological Methods, 2010
- Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin ManufactureScience, 2010
- ω-Transaminases for the synthesis of non-racemic α-chiral primary aminesTrends in Biotechnology, 2010
- Chiral Amine Synthesis – Recent Developments and Trends for Enamide Reduction, Reductive Amination, and Imine ReductionAdvanced Synthesis & Catalysis, 2010
- Iterative saturation mutagenesis (ISM) for rapid directed evolution of functional enzymesNature Protocols, 2007